Tumor promotion as a target for estrogen/antiestrogen effects in rat hepatocarcinogenesis

Preventive Medicine

Volumn 20, Issue 1, 1991, Pages 15-26

  Dragan, Yvonne P ^a   Xu, Yuan ding ^a   Pitot, Henry C ^a  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1' HYDROXYSAFROLE; 2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANTIESTROGEN; CARCINOGEN; ETHINYLESTRADIOL; MESTRANOL; PHENOBARBITAL; PIRINIXIC ACID; TAMOXIFEN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; BREAST CANCER; CONFERENCE PAPER; DRUG CARCINOGENICITY; LIVER CARCINOGENESIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT;

ADENOSINETRIPHOSPHATASE; ADMINISTRATION, ORAL; ANIMAL; CARCINOGENS; DIETHYLNITROSAMINE; DISEASE MODELS, ANIMAL; DRUG EVALUATION, PRECLINICAL; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; GLUCOSEPHOSPHATE DEHYDROGENASE; GLUTATHIONE TRANSFERASE; LIVER NEOPLASMS, EXPERIMENTAL; PHENOBARBITAL; RATS; RATS, INBRED F344; SUPPORT, U.S. GOV'T, P.H.S.; TAMOXIFEN; TUMOR MARKERS, BIOLOGICAL;

EID: 0025980382     PISSN: 00917435     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-7435(91)90003-M     Document Type: Article

References (48)

1. An approach to the development of a short-term whole animal bioassay to distinguish initiating (incomplete) carcinogens complete carcinogens and noncarcinogens in the rat liver
2. Stages in the process of hepatocarcinogenesis in the rat liver
3. Biochemical characterization of stages of hepatocarcinogenesis after a single dose of diethylnitrosamine
4. Characterization of histochemically detectable altered hepatocyte foci and their relationship to hepatic tumorigenesis in rats treated once with diethylnitrosamine or benzo(a)pyrene within one day of birth
5. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci
6. Quantitative studies on multistage hepatocarcinogenesis in the rat
7. Altered hepatic foci: Their role in murine hepatocarcinogenesis
8. Time as a determinant of risk in cancer epidemiology: The role of multi-stage models
9. Studies on the mechanisms involved in multistage carcinogenesis in mouse skin
10. The stages in neoplastic development
11. Kinetics of induction and growth of precancerous liver-cell foci, and liver formation by diethylnitrosamine in the rat
12. Persistence of resistant putative preneoplastic hepatocytes induced by N-nitrosodiethylamine or N-methyl-N-nitrosourea
13. Quantitative stereological analysis of the effect of age and sex on multistage hepatocarcinogenesis in the rat using four cytochemical markers
14. The phenotypic stability of altered hepatic foci: Effects of withdrawal and subsequent readministration of phenobarbital
15. Requirement of cell proliferation for the initiation of liver carcinogenesis as assayed by three different procedures
16. Cell cycle-dependent initiation of adenosine triphosphatase-deficient populations in adult rat liver by a single dose of N-methyl-N-nitrosourea
17. Single GST-P positive cells-putative initiated hepatocytes
18. The quantitative analysis and stability of histochemical markers of altered hepatic foci in rat liver following initiation by diethylnitrosamine administration and promotion by phenobarbital
19. Comparative development and phenotypic properties of altered hepatic foci and hepatic tumors in rats
20. Cancer morbidity under long-term anticonvulsant therapy. A follow-up of 8078 epileptics 1988-1972
21. Early appearance of histochemically altered hepatocyte foci and liver tumors in female rats treated with carcinogens one day after birth
22. Application of quantitative stereology to the evaluation of enzyme-altered foci in rat liver
23. Application of quantitative stereology to the evaluation of phenotypically heterogeneous enzyme-altered foci in the rat liver
24. Quantitative stereological evaluation of four histological markers of altered foci in multistage hepatocarcinogenesis in the rat
25. The pharmacology and clinical uses of tamoxifen
26. The pharmacology of antiestrogens
27. Pharmacology of tamoxifen in laboratory animals
28. The effect of estradiol-17-phenylpropionate and estradiol benzoate on N-nitrosomorpholine-induced liver carcinogenesis in ovariectomized female rats
29. Oral contraceptive steroids as promoters of hepatocarcinogenesis in female Sprague-Dawley rats
30. Role of estrogens as promoters of hepatic neoplasia
31. Regression of liver cell adenomas associated with oral contraceptives
32. Adjuvant tamoxifen in early breast cancer: Occurrence of new primary cancers
33. Induction and promotion of γ-glutamyltranspeptidase-positive foci in the livers of female rats treated with ethinyl estradiol, clomiphene, tamoxifen and their associations
34. Effects of ethinyl estradiol and tamoxifen on liver DNA turnover and new synthesis and appearance of gamma glutamyl transpeptidase positive foci in female rats
35. Quantitative evaluation of the promotion by 2,3,7,8-tetrachlorodibenzo-p-dioxin of hepatocarcinogenesis from diethylnitrosamine
36. The phenotypic stability of altered hepatic foci: Effect of the short-term withdrawal of phenobarbital and of the long-term feeding of the peripheral diets after the withdrawal of phenobarbital
37. A common biochemical pattern in preneoplastic hepatocyte nodules generated in four different models in the rat
38. Regulation and expression of four cytochrome P-450 isozymes, NADPH-cytochrome P-450 reductase, the glutathione transferases B and C and microsomal epoxide hydrolase in preneoplastic and neoplastic lesions in rat liver
39. Activities of benzphetamine-N-demethylase and aryl hydrocarbon hydroxylase in cells isolated from γ-glutamyltranspeptidase-positive foci and surrounding liver
40. Effect of chronic phenobarbital administration on the gammaglutamyl transpeptidase activity of hyperplastic liver lesions induced in rats by the Solt/Farber initiation: Selection process of hepatocarcinogenesis
41. Gamma-glutamyl transpeptidase—its role in hepatocarcinogenesis
42. Histochemische Untersuchungen über die Glucose-6-Phosphatase in der Rattenleber während der Cancerisierung durch Nitrosamine
43. Hepatocellular glycogenosis and related pattern of enzymatic changes during hepatocarcinogenesis
44. γ-Glutamyltranspeptidase-negative phenotypic property of preneoplastic and neoplastic liver lesions induced by ciprofibrate does not change following 2-acetylaminofluorene administration
45. Critical parameters in the quantitation of the stages of initiation, promotion, and progression in one model of hepatocarcinogenesis in the rat